Developing a validated methodology for identifying clozapine treatment periods in electronic health records
Abstract Background Clozapine is the only recommended antipsychotic medication for individuals diagnosed with treatment-resistant schizophrenia. Unfortunately, its wider use is hindered by several possible adverse effects, some of which are rare but potentially life threatening. As such, there is a...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2024-08-01
|
| Цуврал: | BMC Psychiatry |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s12888-024-06022-5 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|